How might MDMA be used to treat post-traumatic stress disorder?


MDMA — more commonly known as ecstasy — is one step closer to becoming a legal form of treatment for post-traumatic stress disorder (PTSD) in the United States.

Researchers have for years been looking at how the drug could be used in conjunction with therapy to help sufferers confront their trauma.

Now the Food and Drug Administration (FDA) has approved it for use in a phase-three clinical trial — the final stage of research required before it can be considered for approval as a prescription drug.

So, what exactly is MDMA, what will the clinical trial involve and what implications might it have for sufferers in Australia?

Read more here:

Share this post

Innovative psychedelic research

The re-emergence of psychedelic research places a crucial emphasis on a holistic approach to mental health from pharmacology, neurobiological process, ecological connection, and therapeutic support.  PRISM supports research and clinical development of therapies where current options provide limited relief.

Your support allows us to pursue cutting edge research for next-generation mental health care.


We are a DGR-1 non-profit research charity developing medical and legal processes for the application of psychedelic medicines for improved wellbeing.


Contact Us

Send us an email and we'll get back to you soon.

Not readable? Change text. captcha txt

Start typing and press Enter to search